Top Medical Stocks To Buy Right Now

tags:PHH,BPT,EDU,TX,KEYS,IONS,

Haemonetics (NYSE: HAE) and Neurometrix (NASDAQ:NURO) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, profitability, earnings and analyst recommendations.

Profitability

Get Haemonetics alerts:

This table compares Haemonetics and Neurometrix’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets Haemonetics 5.04% 12.71% 7.89% Neurometrix -47.75% -161.28% -89.85%

Volatility and Risk

Haemonetics has a beta of 0.93, meaning that its share price is 7% less volatile than the S&P 500. Comparatively, Neurometrix has a beta of 0.26, meaning that its share price is 74% less volatile than the S&P 500.

Top Medical Stocks To Buy Right Now: PHH Corp(PHH)

Advisors' Opinion:

• [By Max Byerly]

  PHH (NYSE:PHH) is scheduled to be announcing its earnings results after the market closes on Tuesday, May 8th. Analysts expect the company to announce earnings of ($0.94) per share for the quarter.

• [By Logan Wallace]

  PHH (NYSE: PHH) and Orix (NYSE:IX) are both finance companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, dividends, valuation, analyst recommendations and profitability.

• [By Stephan Byrd]

  Media headlines about PHH (NYSE:PHH) have been trending somewhat positive recently, Accern Sentiment reports. Accern rates the sentiment of media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. PHH earned a news impact score of 0.17 on Accern’s scale. Accern also gave news coverage about the credit services provider an impact score of 45.9794154743809 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

• [By Max Byerly]

  Orix (NYSE: IX) and PHH (NYSE:PHH) are both finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership.

• [By Ethan Ryder]

  New York State Common Retirement Fund decreased its stake in shares of PHH Co. (NYSE:PHH) by 25.1% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,300 shares of the credit services provider’s stock after selling 9,800 shares during the quarter. New York State Common Retirement Fund’s holdings in PHH were worth $306,000 as of its most recent SEC filing.

Top Medical Stocks To Buy Right Now: BP Prudhoe Bay Royalty Trust(BPT)

Advisors' Opinion:

• [By Joseph Griffin]

  News headlines about BP Prudhoe Bay Royalty Trust (NYSE:BPT) have been trending somewhat positive this week, Accern Sentiment reports. Accern identifies negative and positive news coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. BP Prudhoe Bay Royalty Trust earned a daily sentiment score of 0.09 on Accern’s scale. Accern also gave media headlines about the oil and gas company an impact score of 46.2072909143413 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

• [By Dan Caplinger]

  The stock market had a tumultuous session on Wednesday, as major benchmarks started the day weak but bounced back in the afternoon. Investors weren't happy with the current state of geopolitical uncertainty, with trade disputes threatening to become larger problems than ever. But the release of the minutes of the latest meeting of the Federal Reserve's monetary policy committee convinced many that the central bank will be slow to do lasting damage to the economic expansion, remaining measured in the pace of its interest rate increases. Moreover, some companies had good news that sent their shares higher. Tiffany (NYSE:TIF), BP Prudhoe Bay Royalty Trust (NYSE:BPT), and Ralph Lauren (NYSE:RL) were among the best performers on the day. Here's why they did so well.

• [By Sean Williams]

  As a case in point, consider BP Prudhoe Bay Royalty Trust (NYSE:BPT), which is currently paying out an extrapolated $5.10 a year, based on the $1.275 per share it divvied out in April. This is good enough for a better than 17% annual yield, albeit it should be noted that the Trust's payout differs each quarter depending on its royalty revenue and cash earnings.�

Top Medical Stocks To Buy Right Now: New Oriental Education & Technology Group, Inc.(EDU)

Advisors' Opinion:

• [By Motley Fool Staff]

  In the following segment, we dive into the education industry and the artificial intelligence tools being used by New Oriental Education (NYSE:EDU) and Chegg�(NYSE:CHGG) to boost revenue.

• [By Joseph Griffin]

  Education Management (OTCMKTS: EDMC) and New Oriental Education & Tech Grp (NYSE:EDU) are both consumer discretionary companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, institutional ownership and analyst recommendations.

• [By Ethan Ryder]

  EduCoin (EDU) is a PoW/PoS token that uses the Keccak hashing algorithm. It launched on September 9th, 2017. EduCoin’s total supply is 15,000,000,000 tokens. EduCoin’s official website is www.edu.one. EduCoin’s official Twitter account is @PReducoin.

• [By Ethan Ryder]

  Strayer Education (NASDAQ: STRA) and New Oriental Education & Tech Grp (NYSE:EDU) are both consumer discretionary companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, institutional ownership and profitability.

Top Medical Stocks To Buy Right Now: Ternium S.A.(TX)

Advisors' Opinion:

• [By Logan Wallace]

  Sumitomo (OTCMKTS: SSUMY) and Ternium (NYSE:TX) are both multi-sector conglomerates companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, valuation, analyst recommendations, risk, dividends and profitability.

• [By Lisa Levin] Gainers Genprex, Inc. (NASDAQ: GNPX) shares gained 86.76 percent to close at $11.00 on Thursday. Comstock Resources, Inc. (NYSE: CRK) shares climbed 47.06 percent to close at $7.00 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes. Ceridian HCM Holding Inc. (NASDAQ: CDAY) gained 41.86 percent to close at $31.21. MarineMax, Inc. (NYSE: HZO) shares rose 26.5 percent to close at $22.20 as the company posted upbeat Q2 results and raised its FY18 outlook. Concord Medical Services Holdings Limited (NYSE: CCM) jumped 24.92 percent to close at $4.06. Mattersight Corporation (NASDAQ: MATR) shares climbed 23.26 percent to close at $2.65 after the company agreed to be purchased by NICE Ltd. Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 24.44 percent to close at $422.50 as the company reported stronger-than-expected results for its first quarter on Wednesday. Ultra Clean Holdings, Inc. (NASDAQ: UCTT) gained 17.75 percent to close at $18.64 following upbeat Q1 earnings. PCM, Inc. (NASDAQ: PCMI) rose 16.59 percent to close at $12.30 following Q1 results. Zymeworks Inc. (NASDAQ: ZYME) rose 16.06 percent to close at $15.25. Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares climbed 14.5 percent to close at $121.42 as the company posted reported Q1 beat And raised FY18 outlook. Advanced Micro Devices, Inc. (NASDAQ: AMD) shares gained 13.7 percent to close at $11.04 as the company reported upbeat results for its first quarter. Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 13.21 percent to close at $3.00 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression. O'Reilly Automotive, Inc. (NASDAQ: ORLY) jumped 13.06 percent to close at $257.40 following upbeat Q1 profit. BioTelemetry,
• [By Logan Wallace]

  TT International cut its position in Ternium (NYSE:TX) by 24.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 865,613 shares of the basic materials company’s stock after selling 277,967 shares during the quarter. Ternium makes up about 1.2% of TT International’s holdings, making the stock its 10th biggest position. TT International owned about 0.43% of Ternium worth $28,123,000 at the end of the most recent reporting period.

Top Medical Stocks To Buy Right Now: Keysight Technologies Inc.(KEYS)

Advisors' Opinion:

• [By Logan Wallace]

  Keysight Technologies (NYSE: KEYS) and Orbotech (NASDAQ:ORBK) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, dividends and earnings.

• [By Lisa Levin]

  Thursday morning, the information technology shares surged 0.34 percent. Meanwhile, top gainers in the sector included Keysight Technologies, Inc. (NYSE: KEYS), up 14 percent, and Tech Data Corporation (NASDAQ: TECD) up 8 percent.

• [By Motley Fool Staff]

  Keysight Technologies Inc. (NYSE:KEYS)Q2 2018 Earnings Conference CallMay 30, 2017, 4:30 p.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Lisa Levin] Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) jumped 124.8 percent to $243.725 in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks. Viking Therapeutics, Inc. (NASDAQ: VKTX) gained 63.4 percent to $8.12 after falling 4.42 percent on Wednesday. Takung Art Co., Ltd. (NYSE: TKAT) rose 43.3 percent to $2.9094 vTv Therapeutics Inc. (NASDAQ: VTVT) shares climbed 29.7 percent to $2.16 after the company reported a licensing deal with Newsoara Biopharma to rights for vTv's PDE4 Inhibitor in China and other Pacific Rim territories. Akers Biosciences, Inc. (NASDAQ: AKER) gained 26.2 percent to $0.4109. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days. Genprex, Inc. (NASDAQ: GNPX) rose 22.2 percent to $11.6254. Genprex reported engagement of WIRB-Copernicus Group to provide clinical trial services to support Oncoprex clinical trial program. J.Jill, Inc. (NYSE: JILL) gained 21 percent to $7.506 after the company posted upbeat quarterly earnings. Urban One, Inc. (NASDAQ: UONE) gained 19.7 percent to $3.95 after rising 78.38 percent on Wednesday. TapImmune, Inc. (NASDAQ: TPIV) shares gained 18.5 percent to $6.03 after climbing 24.15 percent on Wednesday. Kirkland's, Inc. (NASDAQ: KIRK) rose 17.3 percent to $12.95 after reporting upbeat Q1 results. CymaBay Therapeutics, Inc. (NASDAQ: CBAY) shares gained 15.1 percent to $13.210. The Brink's Company (NYSE: BCO) climbed 14.2 percent to $77.875 as the company announced plans to acquire Dunbar Armored for $520 million in cash. Keysight Technologies, Inc. (NYSE: KEY
• [By Joseph Griffin]

  OMERS ADMINISTRATION Corp acquired a new stake in shares of Keysight (NYSE:KEYS) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 14,900 shares of the scientific and technical instruments company’s stock, valued at approximately $781,000.

• [By Lisa Levin]

  Thursday afternoon, the information technology shares surged 0.47 percent. Meanwhile, top gainers in the sector included Keysight Technologies, Inc. (NYSE: KEYS), up 12 percent, and QAD Inc. (NASDAQ: QADB) up 11 percent.

Top Medical Stocks To Buy Right Now: Ionis Pharmaceuticals, Inc.(IONS)

Advisors' Opinion:

• [By Keith Speights]

  I think there are four primary arguments for buying Biogen stock. One is the company's soon-to-be blockbuster drug Spinraza. The spinal muscular atrophy (SMA) drug, which Biogen licensed from Ionis Pharmaceuticals (NASDAQ:IONS), won Food and Drug Administration approval near the end of 2016. Spinraza�didn't quite hit the $1 billion sales level in 2017, but it's on track to easily top the magic sales mark this year. Analysts think the drug will reach peak annual sales in the ballpark of $2.5 billion.��

• [By Brian Orelli]

  Shares of Ionis Pharmaceuticals (NASDAQ:IONS) ended the day down 10.6% after an earnings report�from partner Biogen (NASDAQ:BIIB) started the day on a sour note. Then shares dropped even further midday after data was released�for IONIS-HTTRx, a treatment for Huntington's disease. Biogen managed to end the day in the green, up 1.1%.

• [By Lisa Levin] Gainers AGM Group Holdings Inc. (NASDAQ: AGMH) shares climbed 30.3 percent to $11.05 after climbing 34.60 percent on Thursday. Limelight Networks, Inc. (NASDAQ: LLNW) jumped 21.2 percent to $4.9699 following a first-quarter earnings beat. The company also raised its fiscal 2018 estimates. Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) shares climbed 18.8 percent to $7.89 after reporting strong Q1 earnings. Farmers Capital Bank Corp (NASDAQ: FFKT) gained 15.4 percent to $48.75. WesBanco Inc (NASDAQ: WSBC) announced an agreement and plan of merger with Farmers Capital Bank Corporation. TransUnion (NYSE: TRU) climbed 10.2 percent to $66.76 after the company posted upbeat Q1 results and issued a strong forecast for the second quarter. TransUnion announced plans to acquire Callcredit. Myomo, Inc. (NYSE: MYO) shares gained 9.2 percent to $3.9299 after rising 8.11 percent on Thursday. Pinnacle Foods Inc (NYSE: PF) gained 8.8 percent to $60.04 after a 13-D filing from Jana Partners showed an increased stake in the comapny, from 1.42 million shares at the end of last quarter to 10.83 million shares, or a 9.3-percent stake. Associated Banc-Corp (NYSE: ASB) shares climbed 8.8 percent to $26.70 following upbeat Q1 earnings. OFG Bancorp (NYSE: OFG) gained 8.5 percent to $12.80 after reporting Q1 results. Cleveland-Cliffs Inc. (NYSE: CLF) climbed 7.5 percent to $7.73 following Q1 results. Seaspan Corporation (NYSE: SSW) shares climbed 6.7 percent to $7.50. Deutsche Bank upgraded Seaspan from Hold to Buy. General Electric Company (NYSE: GE) shares rose 4.6 percent to $14.63 after the company reported better-than-expected earnings for its first quarter. Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) rose 4.3 percent to $47.80. Biogen and Ionis have expanded their strategic collaboration to develop drug candidates for a broad range of neurological diseases.

  Check out these big penny stock gainers and losers

• [By George Budwell]

  Biogen's top-line growth has now become almost totally dependent on sales of its fairly new spinal muscular atrophy (SMA) drug, Spinraza, that it co-developed with Ionis Pharmaceuticals (NASDAQ:IONS).